lifordi-logo
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Clinical Advisory Board
  • Technology
    • LFD-200
    • Pipeline
  • Clinical Trials
  • News/Events
    • News
    • Events
    • Publications
  • Contact

News/Events

  • About
    • Overview
    • Leadership
    • Board of Directors
    • Clinical Advisory Board
  • Technology
    • LFD-200
    • Pipeline
  • Clinical Trials
  • News/Events
    • News
    • Events
    • Publications
  • Contact

publications

Your filter returned no results. Please try again.

October, 2025

ACR 2025 Poster

LFD-200, an Antibody Drug Conjugate that Selectively Delivers a Glucocorticoid Payload to Immune Cells, Provides Sustained Anti-inflammatory Effects Without Systemic Toxicity in Non-human Primates

June, 2025

EULAR 2025 Poster

Immune-Targeted Glucocorticoid ADC for the Treatment of Autoimmune and Inflammatory Diseases

logo

© Lifordi Immunotherapeutics. All Rights Reserved | Financial Conflict of Interest Policy

1 Van de Graaff Drive, Suite 400
Burlington, MA 01803

logo
  • About
    • Overview
    • Leadership
    • Board of Directors
    • Clinical Advisory Board
  • Technology
    • LFD-200
    • Pipeline
  • Clinical Trials
  • News/Events
    • News
    • Events
    • Publications
  • Contact